FIELD: medicine; pharmacology.
SUBSTANCE: derivatives possess antiproliferative activity and stimulate an apoptosis in cells where absence of normal regulation of development of a cell and its destruction is observed. The derivatives are applied as a part of pharmaceutical compositions in combination with pharmaceutically acceptable mediums. The pharmaceutical compositions can be applied for treatment of diseases caused by hyperproliferation, including tumour growth, lymphoproliterative diseases and angiogenesis. Invention compounds pertain to the group of replaced pyrazoles and Pyrazolinums characterised by the formula of the invention.
EFFECT: derivatives possess useful biological properties.
56 cl, 115 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONDENSED TRIAZOLAMINES AS P2X7 MODULATORS | 2010 |
|
RU2533122C2 |
| DYEING COMPOSITION CONTAINING OXIDIZABLE DIAMINOPYRAZOLE-TYPE BASE, CATIONIC OXIDIZABLE BASE, AND COUPLER | 2003 |
|
RU2245406C2 |
| CARBOXAMIDE COMPOUNDS AND USE THEREOF AS CALPAIN INHIBITORS | 2007 |
|
RU2485114C2 |
| DYEING COMPOSITION HAVING ACID PH VALUE AND INCLUDING 2,3-DIAMINO-6,7-DIHYDRO-1H,5H-PYRAZOLO[1,2-a] PYRAZOL-1-ON, PARA-PHENYLENEDIAMINE, META-AMINOPHENOL AND OXIDISER | 2007 |
|
RU2371169C2 |
| PYRAZOLOPYRIDINE DERIVATIVES AS NADPH-OXIDASE INHIBITORS | 2009 |
|
RU2538041C2 |
| COMPOUNDS AND COMPOSITIONS AS PROTEIN TYROSINE KINASE INHIBITORS | 2006 |
|
RU2386630C2 |
| COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS | 2005 |
|
RU2401265C2 |
| PYRAZOLOPYRIDINE DERIVATIVES AS NADPH OXIDASE INHIBITORS | 2009 |
|
RU2532161C2 |
| PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS | 2007 |
|
RU2485115C2 |
| COMPOUNDS AND COMPOSITIONS AS ITPKb INHIBITORS | 2007 |
|
RU2425826C2 |
